Evaluation of safety and efficacy of laparoscopy-assisted pancreaticoduodenectomy for benign and low-grade malignant tumor

Evaluation of safety and efficacy of laparoscopy-assisted pancreaticoduodenectomy for benign and low-grade malignant tumor - Laparoscopy-assisted pancreaticoduodenectomy for benign and low-grade malignant tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010864

Enrollment

Registered

2013-07-01

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroendocrine tumor mucinous cystic neoplasm serous cystic neoplasm intraductal papillary mucinous neoplasm Solid Pseudopapillary neoplasm , etc.

Interventions

Laparoscopy-assisted pancreaticoduodenectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Benign and low-grade malignant tumor of the pancreatic head 2)ECOG Performance Status:0-1 3)BMI equal to or lower than 25 4)Major organ function is preserved and general anesthesia is possible 5)Signed informed consent

Exclusion criteria

Exclusion criteria: 1)Patients diagnosed as pancreatic ductal carcinoma or suspected 2)Synchronous malignancyes 3)Emergency surgery 4)Acute or chronic pancreatitis 5)Acute cholangitis 6)Women during pregnancy 7)Patients possible to perform enucleation or partial resection 8)Patients judged as inadequate by investigators

Design outcomes

Primary

Measure	Time frame
Complication rate	—

Secondary

Measure	Time frame
Conversion rate Rate of postoperative pancreatic fistula R0 resection rate Postoperative hospital stay	—

Countries

Japan

Contacts

Public ContactTakanori Morikawa

Tohoku University Hospital Division of Hepato-Biliary Pancreatic surgery

t_morikawa@surg1.med.tohoku.ac.jp022-717-7205

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026